Icon Cancer Care
Concord, New South Wales, Australia
Dr Cecelia Gzell is an experienced Radiation oncologist Oncologist who consults and treats patients at multiple Icon Cancer Centre locations across Sydney's outer-metro area including Wahroonga, Concord, and Norwest. She obtained her Bachelor of Medical Science (BMedSc) at the University of Sydney and Bachelor of Medicine (BMed) at the University of Newcastle. Dr Gzell subsequently undertook specialist Radiation oncology Oncology training at the Royal Prince Alfred Hospital prior to becoming a fellow of the Royal Australian and New Zealand College of Radiologists (RANZCR) in 2011. She later completed a post-graduate Neuro-oncology fellowship at Royal North Shore Hospital with research and publications in the field of high-grade gliomas. This research provided the foundations for her PhD focusing on the use of radiation therapy in optimising outcomes of patients with glioblastoma (conferred 2017).
Dr Gzell enjoys a mixture of clinical work and maintains a strong interest in clinical research and education. She is a full member of the Society of Neuro-Oncology (SNO, USA) and is actively involved with the Co-operative Trials Group for Neuro-Oncology (COGNO). Dr Gzell is a regular contributor to leading national and international publications and conferences, and attends weekly multidisciplinary meetings with her colleagues. Her current leadership roles include founder and current secretary of the Stereotactic Interest Group of Australasia (SIGA), board member of the International Stereotactic Radiosurgery Society (ISRS), and senior lecturer at Macquarie University.
Prior to joining Icon, Dr Gzell worked as a Nneuro-oncology Radiation oncology Oncologist at St Vincent’s Private Hospital, Mater Hospital, and Macquarie University Hospitals (2014-2022). She has specialist expertise in the use of stereotactic radiosurgery (including gamma knife surgery) and stereotactic radiation therapy techniques. Her clinical experience covers a broad range of solid tumour malignancies with a special interest in brain cancer and primary and secondary central nervous system (CNS) neoplasms.
